Brenda Gallie
Has grant
Head Retinoblastoma Program
CanadaResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Brenda Gallie is the Head of the Retinoblastoma Program at the Hospital for Sick Children in Canada. Her research focuses on retinoblastoma, including predisposition and surveillance recommendations, metastatic outcomes, and the implications of early diagnosis. She has contributed significantly to the understanding of intraocular retinoblastoma through numerous publications, including topics on staging, treatment response criteria, and the natural history of untreated cases.
Recent Grants
Grant: Close
Preventing RB1 pathway cancers
Open Date: 2014-08-01
Close Date: 2018-07-31
Grant: Close
Genomic characterization of Rb1+/+ retinoblastoma
Open Date: 2014-02-01
Close Date: 2016-01-31
Grant: Close
Multicenter Phase II study for International Intraocular Retinoblastoma Classification Groups B, C & D tumors treated with Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol
Open Date: 2010-09-01
Close Date: 2014-09-30
Grant: Close
The Fourth Annual Kenyan National Retinoblastoma Strategy Meeting & Workshop
Open Date: 2010-04-01
Close Date: 2011-03-31
Grant: Close
The Kenyan National Retinoblastoma Strategy Meeting
Open Date: 2008-09-01
Close Date: 2009-08-31
Articles (9)
Year:
2025
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (3)
Ashwin Mallipatna
Head of Retinoblastoma Program, Staff Pediatric Ophthalmologist & Project Investigator
Hospital for Sick Children
Jack Brzezinski
Associate Professor
University of Washington
Vikas Khetan
-
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.